MoneyWorks4Me

Shilpa Medicare informs about company updates

17 Mar 2018 Evaluate

Shilpa Medicare has informed that the US FDA intimated the Company that based on its inspection from 11th November to 30th November 2017 the Unit of the Company located at S-20 TO S-24/A, pharmaceutical Formulations SEZ TSIIC, Green Industrial Park, Polepally, Jadcherla, Mahabubnagar, Telangana, India, has been determined that the inspection classification of this facility is VAI.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..